Induction of cytochrome P450 2E1 increases hepatotoxicity caused by Fas agonistic Jo2 antibody in mice

被引:45
|
作者
Wang, XD [1 ]
Lu, Y [1 ]
Cederbaum, AI [1 ]
机构
[1] CUNY Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA
关键词
D O I
10.1002/hep.20792
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Cytochrome P450 2E1 (CYP2E1) may be a central pathway in generating oxidative stress, reactive oxygen species, and causing hepatotoxic injury by alcohol and various hepatotoxins. This study evaluated the ability of CYP2E1 to potentiate or synergize the hepatotoxicity of Fas in vivo. C57BL/6 mice were injected intraperitoneally with pyrazole (Pyr) to induce CYP2E1. Then, 16-hour fasted mice were administered agonistic Jot anti-Fas antibody ip. Other mice were treated with Pyr or Jot alone. Levels of serum aminotransferase were 8.3-and 6.3-fold higher in the Pyr/Jo2 group compared with Jot alone, respectively. Histological evaluation of liver showed more extensive acidophilic necrosis and severe pathological changes in the Pyr/Jo2-treated mice. DNA fragmentation and caspase-8 and -3 activities were more elevated in the Pyr/Jo2 group compared with Jot alone. CYP2E1 activity and protein levels were higher in the Pyr/Jo2 group than in Jot alone. Levels of inducible nitric oxide synthase, 3-nitrotyrosine protein adducts, malondialdehyde, and protein carbonyls were also higher in the Pyr/Jo2 group compared with Jot alone. Glutathione and activities of catalase and Cu-Zn superoxide dismutase were decreased in the Pyr/Jo2 group. Administration of chlormethiazole, an inhibitor of CYP2E1, to the Pyr/Jo2-treated mice caused a significant decrease of alanine aminotransferase and liver pathological changes in association with a decrease in CYP2E1 protein and activity. In conclusion, enhanced hepatotoxicity of Fas was found in mice with elevated levels of CYP2E1. We speculate that overexpression of CYP2E1 might synergize and increase the susceptibility to Fas induced-liver injury.
引用
收藏
页码:400 / 410
页数:11
相关论文
共 50 条
  • [1] S-adenosyl-L-methionine attenuates hepatotoxicity induced by agonistic Jo2 fas antibody following CYP2E1 induction in mice
    Wang, XD
    Cederbaum, AI
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 317 (01): : 44 - 52
  • [2] Inactivation of cytochrome P450 2E1 by capsaicin
    Smeal, SJ
    Reilly, CA
    Yost, GS
    FASEB JOURNAL, 2002, 16 (05): : A940 - A941
  • [3] Human and minipig cytochrome P450 2E1
    Baranová, J
    Anzenbacherová, E
    Zuber, R
    Anzenbacher, P
    Soucek, P
    CYTOCHROMES P450, BIOCHEMISTRY, BIOPHYSICS AND DRUG METABOLISM, 2003, : 143 - 147
  • [4] IDENTIFICATION AND INDUCTION OF CYTOCHROME P450 2E1 IN RAT KUPFFER CELLS
    KOOP, DR
    CHERNOSKY, A
    BRASS, EP
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1991, 258 (03): : 1072 - 1076
  • [5] The prevention of carbon tetrachloride induced hepatotoxicity in mice by α-Hederin:: Inhibition of cytochrome P450 2E1 expression
    Jeong, HG
    Park, HY
    BIOCHEMISTRY AND MOLECULAR BIOLOGY INTERNATIONAL, 1998, 45 (01): : 163 - 170
  • [6] Role of cytochrome P450 2E1 in the metabolism of acrylamide and acrylonitrile in mice
    Sumner, SCJ
    Fennell, TR
    Moore, TA
    Chanas, B
    Gonzalez, F
    Ghanayem, BI
    CHEMICAL RESEARCH IN TOXICOLOGY, 1999, 12 (11) : 1110 - 1116
  • [7] DIFFERENT CONTRIBUTIONS OF CYTOCHROME-P450 2E1 AND P450 2B1/2 TO CHLOROFORM HEPATOTOXICITY IN RAT
    NAKAJIMA, T
    ELOVAARA, E
    OKINO, T
    GELBOIN, HV
    KLOCKARS, M
    RIIHIMAKI, V
    AOYAMA, T
    VAINIO, H
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1995, 133 (02) : 215 - 222
  • [8] Cisplatin-induced hepatotoxicity is enhanced by elevated expression of cytochrome P450 2E1
    Lu, YK
    Cederbaum, AI
    TOXICOLOGICAL SCIENCES, 2006, 89 (02) : 515 - 523
  • [9] β-Carotene Increases Activity of Cytochrome P450 2E1 during Ethanol Consumption
    Sandoval, Cristian
    Mella, Luciana
    Godoy, Karina
    Adeli, Khosrow
    Farias, Jorge
    ANTIOXIDANTS, 2022, 11 (05)
  • [10] Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans
    Wang, ZQ
    Hall, SD
    Maya, JF
    Li, L
    Asghar, A
    Gorski, JC
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 55 (01) : 77 - 85